Author | Jeffrey R. Lacasse, PhD

Articles

Consumer Advertisements for Psychostimulants in the United States: A Long History of Misleading Promotion

February 26, 2009

Article

The prescription of psychotropic medications for children continues to be a controversial area of medical practice. In the United States, academic medical centers, medical researchers, prescribers, and the FDA are all ostensibly committed to the common goal of disseminating accurate information and promoting treatment based on scientific evidence. In the United States, however, medical treatment takes place in the context of legal and pervasive direct-to-consumer advertising (DTCA). There are concerns about the potential for DTCA to affect public health negatively and to increase health care costs.

x